SE410312B - Forfarande for framstellning av vissa angivna oximetrar - Google Patents

Forfarande for framstellning av vissa angivna oximetrar

Info

Publication number: SE410312B
Authority: SE; Sweden
Prior art keywords: oximeters; procedure; manufacture; certain stated; stated
Prior art date: 1975-03-20

Application number

SE7603341A

Other languages

English (en)

Swedish (sv)

Other versions

SE7603341L (sv

Inventor

H B A Welle

V Claassen

Original Assignee

Philips Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-03-20

Filing date

1976-03-17

Publication date

1979-10-08

1976-03-17 Application filed by Philips Nv filed Critical Philips Nv

1976-09-21 Publication of SE7603341L publication Critical patent/SE7603341L/xx

1979-10-08 Publication of SE410312B publication Critical patent/SE410312B/xx

Links

238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
YCECQFKWCCEISA-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]pentan-1-one Chemical compound CCCCC(=O)C1=CC=C(C(F)(F)F)C=C1 YCECQFKWCCEISA-UHFFFAOYSA-N 0.000 abstract 1
DBMKBKPJYAHLQP-UHFFFAOYSA-N Azasetron hydrochloride Chemical compound Cl.C1N(CC2)CCC2C1NC(=O)C1=CC(Cl)=CC2=C1OCC(=O)N2C DBMKBKPJYAHLQP-UHFFFAOYSA-N 0.000 abstract 1
102000004316 Oxidoreductases Human genes 0.000 abstract 1
108090000854 Oxidoreductases Proteins 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
150000002923 oximes Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SE7603341A 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar SE410312B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL7503310A NL7503310A (nl)	1975-03-20	1975-03-20	Verbindingen met antidepressieve werking.

Publications (2)

Publication Number	Publication Date
SE7603341L SE7603341L (sv)	1976-09-21
SE410312B true SE410312B (sv)	1979-10-08

Family

ID=19823424

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7603341A SE410312B (sv)	1975-03-20	1976-03-17	Forfarande for framstellning av vissa angivna oximetrar

Country Status (27)

Country	Link
US (1)	US4085225A (de)
JP (1)	JPS6026776B2 (de)
AR (2)	AR211011A1 (de)
AT (1)	AT340895B (de)
AU (1)	AU505358B2 (de)
BE (1)	BE839744A (de)
CA (1)	CA1076142A (de)
CH (4)	CH626057A5 (de)
DD (1)	DD128332A5 (de)
DE (1)	DE2610886A1 (de)
DK (1)	DK144942C (de)
ES (1)	ES446192A1 (de)
FI (1)	FI61875C (de)
FR (1)	FR2304336A1 (de)
GB (1)	GB1535226A (de)
GR (1)	GR60052B (de)
HU (1)	HU171030B (de)
IE (1)	IE43768B1 (de)
IL (1)	IL49238A (de)
IT (1)	IT1063064B (de)
MX (1)	MX9203723A (de)
NL (1)	NL7503310A (de)
PL (3)	PL100052B1 (de)
SE (1)	SE410312B (de)
SU (3)	SU635867A3 (de)
YU (1)	YU39345B (de)
ZA (1)	ZA761434B (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1110460B (it) *	1977-03-02	1985-12-23	Ciba Geigy Ag	Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) *	1988-12-02	1991-03-29	Sanofi Sa	Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) *	1994-08-03	1997-09-09	Hoechst Marion Roussel, Inc.	Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) *	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
EP0759299B1 (de) *	1995-08-16	2000-04-26	Eli Lilly And Company	Potenzierung von Serotonin-Wirkstoffresponz
IN182588B (de)	1998-05-12	1999-05-08	Sun Pharmaceutical Ind Ltd
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (de)	1999-11-12	2001-10-20	Sun Pharmaceutical Ind Ltd
WO2001078721A1 (en) *	2000-04-13	2001-10-25	Mayo Foundation For Medical Education And Research	Aβ42 LOWERING AGENTS
US20080021085A1 (en) *	2000-04-13	2008-01-24	Mayo Foundation For Medical Education And Research	Method of reducing abeta42 and treating diseases
US7256191B2 (en) *	2000-04-24	2007-08-14	Aryx Therapeutics	Materials and methods for the treatment of depression
CA2405025A1 (en)	2000-04-24	2001-11-01	Aryx Therapeutics	(2-aminoethyl) oxime derivatives for the treatment of depression
AU2002342045C1 (en) *	2001-10-12	2009-07-30	Azevan Pharmaceuticals, Inc.	Beta-lactamyl vasopressin Vla antagonists
IL163666A0 (en)	2002-02-22	2005-12-18	New River Pharmaceuticals Inc	Active agent delivery systems and methods for protecting and administering active agents
WO2004071431A2 (en) *	2003-02-05	2004-08-26	Myriad Genetics, Inc.	Method and composition for treating neurodegenerative disorders
EP1651195A4 (de) *	2003-07-11	2007-10-03	Myriad Genetics Inc	Pharmazeutische verfahren, dosierschemata und dosierformen zur behandlung von alzheimerkrankheit
MXPA06002789A (es)	2003-09-12	2006-06-14	Pfizer	Combinaciones que comprenden ligandos alfa-2-delta.
EP1689721B1 (de) *	2003-11-26	2010-07-14	Pfizer Products Inc.	Aminopyrazolderivate als gsk-3-inhibitoren
PL1691811T3 (pl)	2003-12-11	2014-12-31	Sunovion Pharmaceuticals Inc	Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2006001877A2 (en) *	2004-04-13	2006-01-05	Myriad Genetics, Inc.	Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050233010A1 (en) *	2004-04-19	2005-10-20	Satow Philip M	Lithium combinations, and uses related thereto
EP1745180A1 (de) *	2004-04-29	2007-01-24	Keystone Retaining Wall Systems, Inc.	Frontverkleidung für stützwände
WO2006020850A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) *	2004-08-11	2006-02-23	Myriad Genetics, Inc.	Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006102283A2 (en)	2005-03-22	2006-09-28	Azevan Pharmaceuticals, Inc.	Beta-lactamylalkanoic acids for treating premenstrual disorders
PE20061298A1 (es)	2005-04-22	2006-12-24	Wyeth Corp	Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c
WO2006116170A1 (en) *	2005-04-22	2006-11-02	Wyeth	Dihydrobenzofuran derivatives and uses thereof
PE20061319A1 (es) *	2005-04-22	2006-12-28	Wyeth Corp	Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
CA2605554A1 (en)	2005-04-22	2006-11-02	Wyeth	Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
AU2006269231A1 (en)	2005-07-08	2007-01-18	Braincells, Inc.	Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) *	2005-07-14	2007-01-18	Myriad Genetics, Incorporated	Methods of treating overactive bladder and urinary incontinence
PL1910346T3 (pl) *	2005-07-19	2019-09-30	Azevan Pharmaceuticals, Inc.	Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
JP2009502807A (ja) *	2005-07-22	2009-01-29	ミリアドジェネティクス，インコーポレイテッド	薬剤含有率の高い製剤および投与量形態
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (de)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba-rezeptor-vermittelte modulation von neurogenese
FR2912057B1 (fr) *	2007-02-07	2009-04-17	Sanofi Aventis Sa	Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
TW200806300A (en) *	2006-03-24	2008-02-01	Wyeth Corp	New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) *	2006-03-29	2011-01-19	卓郎簑和田	大脳の認知力を用いた疾患治療・予防の方法および医薬
AU2007249399A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US7858611B2 (en) *	2006-05-09	2010-12-28	Braincells Inc.	Neurogenesis by modulating angiotensin
CA2651862A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	5 ht receptor mediated neurogenesis
US20080033045A1 (en) *	2006-07-07	2008-02-07	Myriad Genetics, Incorporated	Treatment of psychiatric disorders
TW200817003A (en) *	2006-07-31	2008-04-16	Sanofi Aventis	Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
WO2008030651A1 (en)	2006-09-08	2008-03-13	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) *	2006-09-14	2010-01-21	Koppel Gary A	Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) *	2006-12-28	2008-07-10	Braincells, Inc.	Modulation of neurogenesis by melatoninergic ligands
EP2125017A2 (de) *	2007-01-11	2009-12-02	Braincells, Inc.	Neurogenese-modulation durch verwendung von modafinil
WO2009128058A1 (en)	2008-04-18	2009-10-22	UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al	Psycho-pharmaceuticals
US20100092479A1 (en) *	2008-08-18	2010-04-15	Combinatorx (Singapore) Pte. Ltd.	Compositions and methods for treatment of viral diseases
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
MX2012004753A (es)	2009-10-23	2012-09-07	Janssen Pharmaceutica Nv	Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina.
EP2509596B1 (de)	2009-12-08	2019-08-28	Case Western Reserve University	Gamma aminosäure zur behandlung von augenerkrankungen
RU2623209C9 (ru)	2010-07-01	2018-01-22	Азеван Фармасьютикалз, Инк.	Способы лечения посттравматического стрессового расстройства
EP2685966A1 (de)	2011-03-17	2014-01-22	Lupin Limited	Pharmazeutische retard-zusammensetzungen eines selektiven serotoninwiederaufnahmehemmers
KR101427221B1 (ko) *	2012-08-29	2014-08-13	주식회사 에스텍파마	플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
PT2981518T (pt)	2013-04-03	2021-06-04	Zcl Chemicals Ltd	Um processo melhorado para a preparação de maleato de fluvoxamina
US10124006B2 (en)	2014-02-07	2018-11-13	MTA Tämogatott Kutatócsoportok Irodája	Use of Sigma-1 receptor agonist compounds
BR112016022575A2 (pt)	2014-03-28	2017-08-15	Azevan Pharmaceuticals Inc	Composições e métodos para o tratamento de doenças neurodegenerativas
RS63296B1 (sr)	2016-03-10	2022-07-29	Janssen Pharmaceutica Nv	Metode lečenja depresije korišćenjem antagonista receptora oreksin-2
US12239125B2 (en)	2016-11-24	2025-03-04	SigmaDrugs Kutató Korlátolt Felelsség Társaság	Compositions for organ preservation
MX2020002762A (es)	2017-09-15	2020-09-17	Azevan Pharmaceuticals Inc	Composiciones y métodos para tratar una lesión cerebral.
JP7739256B2 (ja)	2019-07-19	2025-09-16	バイオエクセルセラピューティクス，インコーポレイテッド	鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en)	2023-01-12	2023-11-07	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3692835A (en) *	1967-04-05	1972-09-19	Jan Van Dijk	Pharmacologically active amino-ethyl oximes

1975
- 1975-03-20 NL NL7503310A patent/NL7503310A/xx not_active Application Discontinuation
1976
- 1976-03-09 ZA ZA761434A patent/ZA761434B/xx unknown
- 1976-03-16 DE DE19762610886 patent/DE2610886A1/de active Granted
- 1976-03-17 HU HU76PI00000513A patent/HU171030B/hu unknown
- 1976-03-17 FI FI760699A patent/FI61875C/fi not_active IP Right Cessation
- 1976-03-17 PL PL1976199556A patent/PL100052B1/pl unknown
- 1976-03-17 DD DD7600191893A patent/DD128332A5/de unknown
- 1976-03-17 SU SU762335241A patent/SU635867A3/ru active
- 1976-03-17 GB GB10703/76A patent/GB1535226A/en not_active Expired
- 1976-03-17 AT AT195476A patent/AT340895B/de active Protection Beyond IP Right Term
- 1976-03-17 CH CH334576A patent/CH626057A5/de active Protection Beyond IP Right Term
- 1976-03-17 DK DK115976A patent/DK144942C/da not_active IP Right Cessation
- 1976-03-17 CA CA248,102A patent/CA1076142A/en not_active Expired
- 1976-03-17 IT IT21320/76A patent/IT1063064B/it active Protection Beyond IP Right Term
- 1976-03-17 GR GR50333A patent/GR60052B/el unknown
- 1976-03-17 SE SE7603341A patent/SE410312B/xx not_active IP Right Cessation
- 1976-03-17 PL PL1976188006A patent/PL100614B1/pl unknown
- 1976-03-17 PL PL1976199557A patent/PL101951B1/pl unknown
- 1976-03-17 IL IL49238A patent/IL49238A/xx unknown
- 1976-03-18 AU AU12147/76A patent/AU505358B2/en not_active Expired
- 1976-03-18 BE BE165316A patent/BE839744A/xx not_active IP Right Cessation
- 1976-03-18 YU YU714/76A patent/YU39345B/xx unknown
- 1976-03-18 ES ES446192A patent/ES446192A1/es not_active Expired
- 1976-03-18 IE IE567/76A patent/IE43768B1/en not_active IP Right Cessation
- 1976-03-19 JP JP51029394A patent/JPS6026776B2/ja not_active Expired
- 1976-03-19 FR FR7608019A patent/FR2304336A1/fr active Granted
- 1976-03-19 US US05/668,461 patent/US4085225A/en not_active Expired - Lifetime
- 1976-03-22 AR AR262650A patent/AR211011A1/es active
- 1976-12-10 AR AR265801A patent/AR211153A1/es active
1977
- 1977-07-12 SU SU772503814A patent/SU645559A3/ru active
- 1977-07-12 SU SU772503815A patent/SU620206A3/ru active
1981
- 1981-03-06 CH CH153981A patent/CH629184A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154081A patent/CH629477A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154181A patent/CH629761A5/de not_active IP Right Cessation
1992
- 1992-06-29 MX MX9203723A patent/MX9203723A/es unknown

Also Published As

Publication number	Publication date
PL100052B1 (pl)	1978-08-31
JPS6026776B2 (ja)	1985-06-25
SU620206A3 (ru)	1978-08-15
NL7503310A (nl)	1976-09-22
CH629477A5 (de)	1982-04-30
YU39345B (en)	1984-10-31
CH626057A5 (de)	1981-10-30
DK115976A (da)	1976-09-21
FI61875C (fi)	1982-10-11
ATA195476A (de)	1977-05-15
DK144942B (da)	1982-07-12
IL49238A (en)	1978-08-31
PL101951B1 (pl)	1979-02-28
SE7603341L (sv)	1976-09-21
CA1076142A (en)	1980-04-22
CH629761A5 (de)	1982-05-14
DD128332A5 (de)	1977-11-09
AT340895B (de)	1978-01-10
AR211153A1 (es)	1977-10-31
IT1063064B (it)	1985-02-11
IE43768L (en)	1976-09-20
ES446192A1 (es)	1977-10-01
SU635867A3 (ru)	1978-11-30
JPS51125345A (en)	1976-11-01
US4085225A (en)	1978-04-18
DE2610886C2 (de)	1987-09-24
GR60052B (en)	1978-04-04
MX9203723A (es)	1992-07-01
PL100614B1 (pl)	1978-10-31
BE839744A (fr)	1976-09-20
DE2610886A1 (de)	1976-10-07
GB1535226A (en)	1978-12-13
FI61875B (fi)	1982-06-30
FI760699A7 (de)	1976-09-21
FR2304336B1 (de)	1979-09-28
AU1214776A (en)	1977-09-22
AR211011A1 (es)	1977-10-14
AU505358B2 (en)	1979-11-15
CH629184A5 (de)	1982-04-15
IE43768B1 (en)	1981-05-20
HU171030B (hu)	1977-10-28
SU645559A3 (ru)	1979-01-30
FR2304336A1 (fr)	1976-10-15
YU71476A (en)	1982-10-31
DK144942C (da)	1982-12-06
ZA761434B (en)	1977-10-26
IL49238A0 (en)	1976-05-31

Legal Events

Date	Code	Title	Description
1994-04-25	SPCF	Application for supplementary protection certificate filed	Free format text: 7603341
1994-10-17	SPCG	Supplementary protection certificate granted	Free format text: 7603341, EXPIRES: 20010317
1995-01-31	NAL	Patent in force	Ref document number: 7603341-4 Format of ref document f/p: F
1996-06-24	NUG	Patent has lapsed	Ref document number: 7603341-4 Format of ref document f/p: F

Publication	Publication Date	Title
SE410312B (sv)	1979-10-08	Forfarande for framstellning av vissa angivna oximetrar
NL7607338A (nl)	1977-01-04	Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit.
AU510466B2 (en)	1980-06-26	Blood substitute based on haemoglobin
DE122005000002I1 (de)	2005-05-12	Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
NL191332C (nl)	1995-06-01	Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
IT7921692A0 (it)	1979-04-09	Prodotto dotato di attivita' sul cervello.
SE7410757L (de)	1975-02-25
SE7905922L (sv)	1980-01-20	N-(diaminofosfinyl)-arylkarboxamider
FR2358160A1 (fr)	1978-02-10	Produit destine a declencher la parturition, a faciliter la fecondation et a augmenter la lactation chez la femme et chez les mammiferes, notamment le betail
BE842927A (fr)	1976-10-01	Procede cyvlique d'oxychlorhydratation d'ethylene avec emissions d'hydrpcarbures reduutes et dichlorure d'ethylenene ainsi obtenu
AU570552B2 (en)	1988-03-17	1,4-dihydropyridine-3-carboxylates and salts thereof
HK17880A (en)	1980-04-11	N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
SE8301997L (sv)	1983-04-11	Framstellning av 6,11-dihydro-11-oxodibens(b,e)-oxepin-2-ettiksyra
SE7509764L (sv)	1976-03-26	Forfarande for framstellning av omega-nor-cykloalkyl-13,14-dehydro-prostaglandiner
NL7902153A (nl)	1979-09-24	Meta-fenoxybenzylesters van fenylalkaanzuren, alsmede insecticiden en acariciden op basis daarvan.
BG34607A3 (bg)	1983-10-15	Фунгицидно средство
USD243123S (en)	1977-01-18	Tibial template for knee joint reconstruction
USD245209S (en)	1977-08-02	Shoe
USD245207S (en)	1977-08-02	Shoe
USD245210S (en)	1977-08-02	Shoe
ES8306467A1 (es)	1983-06-01	Procedimiento para la preparacion de alfa-hidroxiacidos.
SU613421A1 (ru)	1978-06-30	Генератор фалкова
SU640003A1 (ru)	1978-12-30	Стыковое соединение
MX3908E (es)	1981-09-15	Procedimiento para la purificacion de derivados de acido-4,4'-bis-triazenilamino-estilben-2,2'-disulfonico y las sales del mismo
SU523652A1 (ru)	1976-08-05	Культиватор дл ухода за лесными культурами